
Mayne Pharma Group Announces Generic NuvaRing Accepted for Filing by FDA
Mayne Pharma Group Limited (ASX: MYX) announced its Abbreviated New Drug Application (ANDA) for generic NuvaRing® has been accepted for filing by the US Food and Drug Administration (FDA). NuvaRing is an intra vaginal hormonal contraceptive delivery device combining etonogestrel … Continue reading Mayne Pharma Group Announces Generic NuvaRing Accepted for Filing by FDA